Featured Research

from universities, journals, and other organizations

Tight Blood Pressure Control Not Enough To Temper Kidney Disease In African-Americans

Date:
April 30, 2008
Source:
Johns Hopkins Medical Institutions
Summary:
Even when their blood pressure is kept strictly under control with the best available medicine, African-American patients with chronic kidney disease continue to lose their kidney function over time, research shows. The finding suggests that treating CKD in this population may be vastly more complex than researchers had previously thought, with blood pressure control being only one piece of the therapeutic puzzle.

Even when their blood pressure is kept strictly under control with the best available medicine, African-American patients with chronic kidney disease (CKD) continue to lose their kidney function over time, research led by a Johns Hopkins team shows. The finding suggests that treating CKD in this population may be vastly more complex than researchers had previously thought, with blood pressure control being only one piece of the therapeutic puzzle.

The study, called AASK (African-American Study of Kidney Disease and Hypertension), is the longest to date focusing on blood pressure in patients with CKD. AASK followed 1,094 African-American patients with this condition for up to 11 years. Through a combination of medications, most of these patients kept their blood pressure in the recommended range for CKD, lower than 130/80. However, the vast majority still went on to develop steadily worsening kidney function, often leading to dialysis, kidney transplantation, or death.

"Kidney disease still progressed at an alarming rate, even when our participants received outstanding medical care for their high blood pressure," says study leader Lawrence Appel, M.D., professor of medicine at the Johns Hopkins School of Medicine. "Blood pressure is important, but it's not the whole picture. We still have a long way to go in figuring out the best way to treat patients with CKD."

Appel and his colleagues at 21 clinical centers across the country chose to focus their study on African Americans, who suffer disproportionately from kidney disease associated with high blood pressure. In whites, high blood pressure causes about 19 percent of all end-stage renal disease cases, in which kidneys have essentially lost their function. In African-Americans, the corresponding figure is about 37 percent.

Researchers aren't sure why high blood pressure often leads to CKD. The prevailing theory is that high pressure strains delicate tufts of capillaries known as glomeruli, which filter blood and create urine in kidneys.

To investigate whether keeping blood pressure low would slow or possibly stop CKD progression, the researchers designed their study in two phases; the first would take place between February 1995 and September 2001, and the second between October 2001 and June 2007.

In the first phase, the researchers randomly assigned all 1,094 patients to one of three drugs commonly used to lower blood pressure-an ACE inhibitor, a -blocker, or a calcium channel blocker. Each patient was also assigned to one of two blood pressure goals-a standard goal (about 140/90 or lower), and a more aggressive goal (130/80 or lower). The researchers tracked each patient's blood pressure and kidney function, determined through blood and urine tests, as well as their overall health.

At the end of the first phase, the researchers found that about a third of the patients had lost at least half their kidney function, developed end-stage renal disease, or died, even though almost all of the patients were well within their blood pressure goals. Of the remaining patients, the scientists recruited 759 to continue on to the study's next phase, in which they capitalized on what they'd learned so far. Early findings from the first phase showed that the ACE inhibitor worked better than the other treatments, so the remaining patients began taking that drug. They were also given the more aggressive blood pressure goal of 130/80.

Over the next five years, the researchers again tracked patients' blood pressure, kidney function, and overall health. However, regardless of their new and improved treatment, a third of these patients still lost at least half their kidney function, developed end-stage renal disease, or died.

These results, published in the April 28 Annals of Internal Medicine, shouldn't discourage patients with CKD from continuing their blood pressure therapy, says Appel. "Outcomes would certainly be worse if they didn't control their blood pressure," he explains. However, he adds that the findings suggest that other factors beyond just blood pressure may be at play in worsening CKD. Blood pressure spikes at night, high salt intake, or exposure to heavy metals like lead or mercury may influence kidney disease progression. "Lots of different factors need examining," says Appel.

He and his colleagues plan to investigate these additional factors in future studies. Another Hopkins researcher contributing to the study was Jeanne Charleston, R.N.

This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Center for Minority Health and Health Disparities, and King Pharmaceuticals Company.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Tight Blood Pressure Control Not Enough To Temper Kidney Disease In African-Americans." ScienceDaily. ScienceDaily, 30 April 2008. <www.sciencedaily.com/releases/2008/04/080428162526.htm>.
Johns Hopkins Medical Institutions. (2008, April 30). Tight Blood Pressure Control Not Enough To Temper Kidney Disease In African-Americans. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2008/04/080428162526.htm
Johns Hopkins Medical Institutions. "Tight Blood Pressure Control Not Enough To Temper Kidney Disease In African-Americans." ScienceDaily. www.sciencedaily.com/releases/2008/04/080428162526.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins